The Trump administration is proposing that companies be required to disclose the cost of drugs in legible print on all video advertisements. The pharmaceutical industry is fighting back, arguing that consumers should be able to find the price elsewhere and that few people end up paying the list price anyway. Faculty Associate Gerard Anderson is quoted.